Study guide

4.3 Patient History, Contraindications, and Pregnancy Screening

ARRT Bone Densitometry Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Orientation & the ARRT Blueprint

1.1 About the ARRT Bone Densitometry Examination 1.2 Eligibility, Structured Education, and Clinical Experience

2 Chapter 2: Osteoporosis, Bone Biology & Risk Factors

2.1 Osteoporosis: Definitions, Types, and WHO Diagnostic Criteria 2.2 Bone Functions, Structural Anatomy, and Bone Types 2.3 Bone Cells, the Remodeling Cycle, and Calcium Homeostasis 2.4 Risk Factors, Secondary Causes, and Bone-Compromising Medications

3 Chapter 3: Indications, Prevention & Treatment

3.1 The Bone Mass Measurement Act: Covered Indications and Coding 3.2 Prevention: Nutrition, Exercise, Smoking Cessation, and Fall Prevention 3.3 Osteoporosis Drug Therapy: Antiresorptive, Anabolic, and Hormonal Agents

4 Chapter 4: Patient Preparation, Support & Radiation Safety

4.1 Patient Support, Disabilities, Ergonomics, and Transfer Techniques 4.2 Patient Instructions: Explaining the Exam, Dose, Duration, and Motion Control 4.3 Patient History, Contraindications, and Pregnancy Screening 4.4 Scan Preparation: Patient Data Entry, Artifact Removal, and Infection Control 4.5 Radiation Safety in DXA: ALARA, Distance, and Dose Levels

5 Chapter 5: DXA Physics & Instrumentation

5.1 Physical Principles of Dual-Energy X-ray Absorptiometry 5.2 Beam Geometries: Pencil Beam and Fan Beam Systems 5.3 Fan-Beam Geometry: Source–Object–Detector Distances, Magnification, and Centering 5.4 The Scan Analysis Algorithm: Soft Tissue, Bone Edge Detection, BMC, Area, and BMD

6 Chapter 6: Measuring & Reporting Bone Mineral Density

6.1 Statistics for Densitometry: Mean, Standard Deviation, and Coefficient of Variation 6.2 T-Scores, Z-Scores, and Reference Database Selection 6.3 Clinical Indications for BMD Testing and the FRAX Tool 6.4 Vertebral Fracture Assessment and Trabecular Bone Score 6.5 Whole Body DXA, Body Composition, and Pediatric Scanning

7 Chapter 7: Quality Control, Precision & Equipment Management

7.1 Accuracy, Precision, and the Sources of Precision Error 7.2 Daily Quality Control, Phantoms, and Control Charts 7.3 In Vivo Precision Studies and RMS-SD Calculation 7.4 Determining and Applying the Least Significant Change 7.5 Maintenance, Repair, Relocation, Cross-Calibration, and Software Upgrades

8 Chapter 8: DXA Informatics & Data Management

8.1 DXA Informatics, DICOM, PACS, and Data Management

9 Chapter 9: Lumbar Spine DXA

9.1 Lumbar Spine Anatomy, Landmarks, and Regions of Interest 9.2 Lumbar Spine Scan Acquisition and ROI Edge Placement 9.3 Lumbar Spine: Compensating for Body Habitus, Variant Anatomy, Pathology, and Low Bone Density 9.4 Lumbar Spine Positioning: The Leg Block, Centering, and Common Challenges 9.5 Lumbar Spine Problems: Poor Bone Edge Detection and Obscured Intervertebral Spaces 9.6 Lumbar Spine: Variant Anatomy, Fractures, Degenerative Pathology, Calcification, and Surgery 9.7 Lumbar Spine Analysis: Vertebral Exclusion and Reporting Rules 9.8 Lumbar Spine Follow-Up Scans and Rate of Change

10 Chapter 10: Proximal Femur DXA

10.1 Proximal Femur Anatomy, Landmarks, and Regions of Interest 10.2 Femur Selection: Right, Left, and Dual Femur Scanning 10.3 Proximal Femur Scan Parameters and Compensation 10.4 Proximal Femur Positioning: Neck Rotation, Shaft Placement, and Positioning Aids 10.5 Proximal Femur Problems: Ischium, Short Neck, Arthritis, Fracture, and Hardware 10.6 Femoral ROI Analysis: Femoral Neck, Total Hip, and Ward's Area 10.7 Proximal Femur Follow-Up Scans and Rate of Change

11 Chapter 11: Forearm DXA

11.1 Forearm Anatomy, Landmarks, and Adjacent Structures 11.2 Forearm Indications and Side Selection 11.3 Forearm Length Measurement, Scan Parameters, and Positioning 11.4 Forearm Regions of Interest: One-Third, Mid, Ultradistal, and Total 11.5 Forearm Problems: Edge Detection, Artifacts, Low Bone Density, and Joint Disease 11.6 Scan Analysis: Region Placement, Window Level, and Reported Values 11.7 Forearm Follow-Up Scans and Rate of Change

12 Chapter 12: Cross-Site Artifacts & Clinical Integration

12.1 Recognition, Impact, and Management of DXA Artifacts 12.2 Clinical Interpretation, Serial Comparison, and Reporting

4.3 Patient History, Contraindications, and Pregnancy Screening

Key Takeaways Explain This Topic AI

Patient verification mandates two unique identifiers, accurate capture of sex assigned at birth and ethnicity for reference database selection, and direct measurement of height and weight on calibrated clinic equipment.

Historical height loss greater than 1.5 inches (4.0 cm) or prospective height loss exceeding 0.8 inches (2.0 cm) strongly suggests silent vertebral compression fracture and warrants vertebral imaging.

Pregnancy represents an absolute contraindication for elective screening DXA; technologists must enforce the 10-day rule and pre-scan screening questionnaires for patients of childbearing potential.

Radiopaque contrast media (barium sulfate, CT iodinated contrast) artificially attenuate the dual-energy x-ray beam and falsely elevate measured BMD; a mandatory clearance period of 1 to 2 weeks is required prior to scanning.

In vivo nuclear medicine radiopharmaceuticals corrupt scintillation detector counts and require 48 to 72 hours (or 10 half-lives) clearance, while oral calcium supplements must be withheld for 24 hours to prevent radiopaque tablet artifacts over the lumbar spine.

Last updated: September 2026

4.3 Patient History, Contraindications, and Pregnancy Screening

High-quality dual-energy x-ray absorptiometry begins well before x-ray exposure. Systematic patient verification, medical history acquisition, contraindication screening, and pre-scan attire preparation are critical technologist responsibilities. Errors during intake compromise patient safety, distort attenuation calculations, and generate misleading clinical interpretations.

Pre-Scan Patient History Verification and Intake Protocol

Clinical standards mandate verifying patient identity using two unique identifiers , typically full legal name and date of birth. Beyond identity confirmation, several demographic parameters directly govern software calculations:

Age and Date of Birth: Software algorithms calculate age-matched Z-scores and FRAX probabilities directly from date of birth. Entry errors distort reference calculations.

Sex Assigned at Birth: Peak adult bone mass and reference distribution curves differ significantly between biological sexes. Normative databases compare patients against sex-matched young-normal reference cohorts. For transgender patients, clinicians enter natal sex or sex concordant with hormone therapy exceeding five years.

Race and Ethnicity: Skeletal geometry and peak bone mass vary across ethnic backgrounds. Major DXA manufacturers provide databases for Caucasian, African American, Hispanic, and Asian populations to ensure valid standard deviation reference comparisons.

Direct Physical Measurement Standards: Height and Weight

Accurate height and weight measurements are essential. Facilities must never rely on self-reported values , as patients systematically overestimate height and underestimate weight:

Scanner software utilizes BMI and tissue thickness to select acquisition modes (thin, standard, or thick). Erroneous data leads to incorrect tube current or scan speed selection, degrading image quality.

Direct measurement identifies occult vertebral compression fractures.

Clinical Height Loss Thresholds

Vertebral compression fractures frequently develop asymptomatically without acute trauma. Two validated height loss thresholds mandate clinical investigation:

Historical Height Loss > 1.5 inches (> 4.0 cm): Difference between measured current standing height and recalled peak young-adult height.

Prospective Height Loss > 0.8 inches (> 2.0 cm): Documented height loss between consecutive clinical appointments.

When either threshold is crossed, the technologist must notify the interpreting physician and recommend Vertebral Fracture Assessment (VFA) or spinal radiographs to evaluate for silent vertebral collapse.

Structured Pre-Scan Intake Questionnaire

The pre-scan questionnaire identifies clinical risk factors, previous examinations, and technical scanning impediments:

Category Clinical Screening Query Diagnostic Rationale

Prior DXA Date, facility, and scanner model of prior exams Establishes comparability; cross-calibration needed across models

Fractures Sites, dates, and trauma level of adult fractures Identifies fragility fractures; excludes fractured vertebrae from ROI

Hardware Spinal fusion rods, clips, or hip arthroplasty Hardware elevates BMD; mandates scanning contralateral hip/forearm

Endocrine / GI Hyperparathyroidism, celiac disease, thyroid disease Identifies secondary osteoporosis etiologies modifying interpretation

Medications Glucocorticoid use, aromatase inhibitors, Lupron High-risk medications requiring baseline assessment and monitoring

Contraindications in Bone Densitometry

Central DXA is non-invasive, yet key contraindications exist:

Pregnancy (Absolute Contraindication for Screening): Elective screening densitometry is strictly contraindicated during pregnancy to eliminate fetal ionizing radiation exposure. In female patients of reproductive potential (ages 12 to 55), technologists must apply the 10-day rule (scheduling examinations within the first 10 days following the onset of menses) or administer a pregnancy screening questionnaire. If missed menses or pregnancy uncertainty exists, a clinical pregnancy test must be completed prior to scanning.

Positional Limitations: Patients unable to lie supine due to severe kyphosis, pain, or respiratory distress cannot undergo central spine and hip imaging. In such cases, the nondominant forearm serves as an alternative peripheral site.

Weight Capacity: DXA tables have weight limits (typically 350 to 500 lbs / 159 to 227 kg). Exceeding limits damages drive motors and invalidates magnification calibration.

Interfering Substances and Radiopaque Artifacts

Exogenous radiopaque substances in the scan field distort beam attenuation, producing spurious BMD values:

Radiopaque Contrast Media (Barium & CT Contrast): Barium sulfate (Z = 56) and iodinated contrast (Z = 53) attenuate x-ray beams. Retained contrast overlying the lumbar spine or pelvis simulates hyperdense bone, falsely elevating measured BMD and masking osteoporosis. Mandatory wait time: 1 to 2 weeks (7 to 14 days) for gastrointestinal clearance. A scout scan can verify clearance if uncertain.

Nuclear Medicine Radiopharmaceuticals: Injected radionuclides (e.g., Technetium-99m, Iodine-131, PET tracers) emit gamma rays that strike DXA detectors, adding false counts and corrupting attenuation ratios. Mandatory wait time: 48 to 72 hours (or 10 physical half-lives) of the isotope.

Oral Calcium Supplements: Calcium tablets taken on exam day may remain undissolved in bowel overlying L1–L4, creating focal radiopacities that falsely elevate spine BMD. Patients must abstain from calcium supplements for 24 hours prior to scanning.

Substance Mechanism of Interference Impact on BMD Clearance Window

Barium Sulfate Dense GI contrast overlying L1–L4 / pelvis False marked elevation; masks osteoporosis 1 to 2 weeks (7–14 days)

CT Contrast High-Z iodine attenuates dual-energy beam False regional BMD elevation 1 to 2 weeks (7–14 days)

Radiotracers Gamma emissions strike scintillation detectors Corrupts detector counts; invalidates exam 48 to 72 hours (or 10 half-lives)

Calcium Tablets Undissolved radiopaque tablet over spine Falsely elevates focal vertebral BMD 24 hours prior to scan

Patient Attire and Artifact Removal

Before scanning, patients must remove external metallic and radiopaque items: zippers, snaps, buttons, wire hooks, underwire bras, buckles, jewelry, body piercings between mid-chest and thighs, and metallic transdermal patches. Patients should change into a metal-free cotton gown or scrub pants without fasteners.